ValueScreener company report

Anterix Inc. (ATEX)

Name: Anterix Inc. (ATEX) filed financial figures
Creator: ValueScreener

NASDAQ / Communication Services / Telecommunications Services

Share price

84.48 USD Market dataClose of Oct 15, 2026

Market capitalisation

1.66B USD Market dataClose of Oct 15, 2026

Market data: Oct 15, 2026
Filed accounts: FY2026, filed Jun 25, 2026
Ratios computed: Oct 15, 2026
Filed years: 13, FY2013 to FY2026

Four kinds of sourceSEC filingCompany statementMarket dataComputedWhat each means

SEC filingFiled with the SEC: Read from a statement the company filed with the SEC, with the form, fiscal year, filing date and accession beside it.
Company statementCompany statement: What the company says about itself in a filing: an 8-K item, the auditor, its own segment names.
Market dataMarket data: Prices, market value and what analysts publish, with the date they are as of.
ComputedComputed by ValueScreener: Worked out by us from the other three, with the inputs and the formula one press away. A score is a research output, not a rating or a recommendation.

Reading

1 of 10

Overview

What the business is, what it costs, and how it reads on four questions.

Market dataSEC filingComputed

Quality

Return on equity

34.5% Computed

From the FY2026 filing

Read quality

Financial strength

Current ratio

3.33 Computed

From the FY2026 filing

Read financial strength

Valuation

Price to earnings

17.42x Computed

FY2026 accounts, priced at the latest close

Read valuation

Cash generation

Free cash flow yield

0.3% Computed

FY2026 accounts, priced at the latest close

Read cash generation

Revenue and net income, as filed

Revenue Net income10 filed fiscal years, from the annual reports; the table in Filings names each document.

Named tests met: 0 of 30 Which tests

The business, and the score behind its five axes

The reading, in brief

Is it cheap

Price to earnings is 17.42x at the close of 2026-10-15 on FY2026 figures; the lines are 15.00x (Graham's defensive ceiling) and, by market convention, 10.00x, 25.00x and 40.00x, and this sits between 15.00x and 25.00x.

Today, against the Telecommunications Services industry (31 companies), 17.42x sits at the 63rd percentile; the middle half of that group runs from 8.97x to 23.29x.

Is it good

Return on equity was 34.5% in FY2026, in the band labelled "Exceptional, check the leverage" (25.0% and above), on lines anchored on Damodaran's cost-of-capital data, suggesting high returns on shareholders' money, which leverage can also produce.

Today, against the Telecommunications Services industry (46 companies), 34.5% sits at the 94th percentile; the middle half of that group runs from -3.6% to 19.5%.

Is it safe

Current ratio was 3.33 in FY2026, in the band labelled "At or above Graham's requirement" (2.00 and above), on lines anchored on Graham's defensive-investor criteria, suggesting short-term assets well above short-term obligations.

Today, against the Telecommunications Services industry (47 companies), 3.33 sits at the 96th percentile; the middle half of that group runs from 0.87 to 1.83.

Year by year against peers: Whether Anterix Inc.'s return on equity stayed above the median of the Telecommunications Services industry, year by year. (FY2017 to FY2026, 10 fiscal years of Anterix Inc. with a comparable figure)
The direction: Which way Anterix Inc.'s return on equity has moved, and how steadily. (FY2017 to FY2026, 10 filed years of Anterix Inc.)
What could explain it: What in Anterix Inc.'s filed statements could explain the movements. (3 readings drawn from the statement lines Anterix Inc. filed)
What to check next: What to check next on Anterix Inc., and where in its filings. (2 questions for Anterix Inc.)
In one paragraph: One paragraph on Anterix Inc.'s returns, cash, balance sheet and price. (6 of sixteen figures read for Anterix Inc.)

These are ATEX’s filed figures. The research desk says what they mean, against peers and its own years, with what to check next.

Research ATEXPart of Serious. New accounts start with 30 days of Professional, free, no card.

2 of 10

What changed

The newest filing, what it moved, and when the next one is due.

SEC filingCompany statement

The newest accounts on file are the FY2026 annual report: 10-K, filed Jun 25, 2026, accession 0001304492-26-000027.

3 of 10

Quality

The returns the business earns on its capital, and the margins behind them.

SEC filingComputed

Anterix Inc: returns on capital and margins, each with its source
Figure	Value, source and document
Return on invested capital, after tax Why n/a The filed borrowings do not add up to a total we can stand behind: the filer's own liability subtotals leave room for debt we did not read.	n/a ComputedFY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027
Return on equity	34.5% ComputedFY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027
Return on capital employed, pre-tax	21.9% ComputedFY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027
Return on assets	19.5% ComputedFY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027
Gross margin Why n/a Our archived statements for this filer carry no gross profit line, so there is nothing to compute a gross margin from and trace back to source. That may be because the filer presents no cost of revenue, or because we have not captured the concept. We do not guess which.	n/a ComputedFY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027
Operating margin Why n/a Our copy of this filing shows an operating income many times the revenue above it, which that revenue cannot produce, so the revenue line we hold is wrong. We show nothing built on it.	n/a ComputedFY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027
Net margin Why n/a Our copy of this filing shows an operating income many times the revenue above it, which that revenue cannot produce, so the revenue line we hold is wrong. We show nothing built on it.	n/a ComputedFY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027

4 of 10

Financial strength

What it owes against what it owns, and whether it can meet what falls due.

SEC filingComputedCompany statement

Anterix Inc: leverage, liquidity and distress, each with its source
Figure	Value, source and document
Debt to equity Why n/a The filed borrowings do not add up to a total we can stand behind: the filer's own liability subtotals leave room for debt we did not read.	n/a ComputedFY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027
Current ratio	3.33 ComputedFY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027
Quick ratio	3.33 ComputedFY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027
Interest coverage Why n/a No interest expense is filed for this year, so coverage is not computed.	n/a ComputedFY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027
Altman Z-score Why n/a Our copy of this filing shows an operating income many times the revenue above it, which that revenue cannot produce, so the revenue line we hold is wrong. We show nothing built on it.	n/a ComputedClose of Oct 15, 2026 · FY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027
Net debt Why n/a The FY2026 balance sheet carries no net debt we could read.	n/a ComputedFY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027

Total assets Total liabilities Shareholders’ equity

The balance sheet, line by line

Financial health

What Anterix Inc owned and owed at the end of fiscal 2026, from the balance sheet it filed (10-K, filed Jun 25, 2026, 0001304492-26-000027).

Anterix Inc: balance sheet position
Total assets	465.2M FiledFY2026 10-K, filed Jun 25, 2026
Total liabilities	202.9M FiledFY2026 10-K, filed Jun 25, 2026
Shareholders' equity	262.3M FiledFY2026 10-K, filed Jun 25, 2026
Cash	98.5M FiledFY2026 10-K, filed Jun 25, 2026
Total debt	n/a FiledFY2026 10-K, filed Jun 25, 2026
Net debt	n/a
Current ratio	3.33
Debt to equity	n/a

Debt to equity: FY2026: The filed borrowings do not add up to a total we can stand behind: the filer's own liability subtotals leave room for debt we did not read.
Interest cover: FY2026: No interest expense is filed for this year, so coverage is not computed.

Read from the filed balance sheet for each year, with the income statement of the same year supplying operating profit where a ratio needs it. Nothing here is a view on whether this company is sound.

5 of 10

Valuation context

What the market charges for it, against its own record and companies like it.

Market dataSEC filingComputed

Anterix Inc: what the market charges, each with its source
Figure	Value, source and document
Price to earnings	17.42x ComputedClose of Oct 15, 2026 · FY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027
P/E on trailing twelve months	24.32x ComputedClose of Oct 15, 2026 · Trailing four quarters, each as known on the day; the quarterly filings are listed under Filings
Price to book	6.04x ComputedClose of Oct 15, 2026 · FY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027
Price to sales Why n/a Our copy of this filing shows an operating income many times the revenue above it, which that revenue cannot produce, so the revenue line we hold is wrong. We show nothing built on it.	n/a ComputedClose of Oct 15, 2026 · FY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027
Enterprise value to EBIT Why n/a We do not hold this figure for this company, so there is nothing to show.	n/a ComputedClose of Oct 15, 2026 · FY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027
Enterprise value to EBITDA Why n/a We do not hold this figure for this company, so there is nothing to show.	n/a ComputedClose of Oct 15, 2026 · FY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027
Price to earnings over growth Why n/a We do not hold this figure for this company, so there is nothing to show.	n/a ComputedClose of Oct 15, 2026 · FY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027
Diluted earnings per share	4.83 USD FiledFY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027
Graham number	39.07 USD ComputedFY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027

We publish no fair value or price target of our own. Value ATEX on your own assumptions in the DCF workbench, starting from the filed figures.

Its own record, and companies like it

Valuation

What the market charges for Anterix Inc today, and the multiples it has carried. No value of ours: the figures are the filings’ and the market’s.

Anterix Inc: valuation
Share price	84.48 USD
Market capitalisation	1.66B USD
Enterprise value to EBITDA	n/a
Graham number	39.07 USD
Diluted earnings per share, FY2026	4.83 USD

Price to earnings on trailing twelve months, a different basis from the fiscal-year P/E above, since Oct 3, 2016: low 3.58x, median 10.80x, high 89.74x, latest 24.32x. 357 trading days with a meaningful ratio, 2,164 more on a loss and left out. Each close over the trailing twelve months of earnings as known that day: a quarter counts from the day it was filed.

Companies like Anterix Inc

Same industry (Telecommunications Services) and size band (Small, 300M to 2B), nearest in market value and current ratio. Each of those counts equally, by how many of the companies considered sit between the two on it. Closest first: the order is likeness and nothing else.

6 of 10

Cash generation

Whether profit arrives as cash, and what is paid back to shareholders.

SEC filingComputed

Anterix Inc: cash generation and what is paid out, each with its source
Figure	Value, source and document
Free cash flow yield	0.3% ComputedClose of Oct 15, 2026 · FY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027
Free cash flow	5.5M USD ComputedFY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027
Free cash flow margin Why n/a Our copy of this filing shows an operating income many times the revenue above it, which that revenue cannot produce, so the revenue line we hold is wrong. We show nothing built on it.	n/a ComputedFY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027
Dividend yield Why n/a We do not hold this figure for this company, so there is nothing to show.	n/a ComputedClose of Oct 15, 2026 · FY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027
Payout ratio Why n/a We do not hold this figure for this company, so there is nothing to show.	n/a ComputedFY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027

Free cash flow Net incomeProfit that arrives as cash stands level with net income; a gap year after year is worth reading about.

7 of 10

Filings

Every figure, the year it is for and the document it was read from.

SEC filingMarket data

The filed figures

Computed from the accounts this company filed with the SEC and, in a ratio with a price in it, the last close, dated on this page. Every filed figure below carries the fiscal year and the filing date its accounts were read from, and every blank carries the reason it is blank. Nothing here is a view on this company.

Anterix Inc.: the eight ratios, with the fiscal year and filing date behind each.
Figure	Value	Year	As of
	17.42x	FY2026	Oct 15, 2026
FormulaShare price / earnings per share. Where the filing states no earnings per share this listing can be priced on, which is every 20-F and 40-F filer because theirs is stated per ordinary share, it is market capitalisation / net income: the same multiple, undiluted. As ofThe close on Oct 15, 2026, over the filed figures of FY2026: a price is in this figure, and it moved after the filing. Form10-KFiledJun 25, 2026PeriodFY2026Accession0001304492-26-000027What we read from itIncome statementFY2026Open on SEC.gov, accession 0001304492-26-000027, leaves this page and opens in a new tab
	6.04x	FY2026	Oct 15, 2026
FormulaMarket capitalisation / shareholders equity As ofThe close on Oct 15, 2026, over the filed figures of FY2026: a price is in this figure, and it moved after the filing. Form10-KFiledJun 25, 2026PeriodFY2026Accession0001304492-26-000027What we read from itBalance sheetFY2026Open on SEC.gov, accession 0001304492-26-000027, leaves this page and opens in a new tab
	n/a	FY2026	Oct 15, 2026
n/a Enterprise value is the market value plus total debt less cash, and the filed balance sheet reports no debt total or no cash.
Formula(Market capitalisation + total debt - cash) / operating income, or over the filing's own EBIT (income before tax + interest expense) where the filer tags no operating line, as Johnson & Johnson does not in any of its ten filed years. As ofThe close on Oct 15, 2026, over the filed figures of FY2026: a price is in this figure, and it moved after the filing. Form10-KFiledJun 25, 2026PeriodFY2026Accession0001304492-26-000027What we read from itIncome statementFY2026Open on SEC.gov, accession 0001304492-26-000027, leaves this page and opens in a new tabForm10-KFiledJun 25, 2026PeriodFY2026Accession0001304492-26-000027What we read from itBalance sheetFY2026Open on SEC.gov, accession 0001304492-26-000027, leaves this page and opens in a new tab
	0.3%	FY2026	Oct 15, 2026
FormulaFree cash flow per share / share price x 100 As ofThe close on Oct 15, 2026, over the filed figures of FY2026: a price is in this figure, and it moved after the filing. Form10-KFiledJun 25, 2026PeriodFY2026Accession0001304492-26-000027What we read from itCash flow statementFY2026Open on SEC.gov, accession 0001304492-26-000027, leaves this page and opens in a new tab
	n/a	FY2026	Jun 25, 2026
n/a The filed borrowings do not add up to a total we can stand behind: the filer's own liability subtotals leave room for debt we did not read.
FormulaVendor trailing-twelve-month return on invested capital where one is published, which uses after-tax operating profit over total assets less current liabilities. Otherwise our own recompute: NOPAT / (shareholders equity + total debt - cash) x 100, where NOPAT is the filed operating profit after tax, or the filing's own EBIT after tax where the filer tags no operating line. As ofThe filing date of the statements below, for FY2026. Form10-KFiledJun 25, 2026PeriodFY2026Accession0001304492-26-000027What we read from itIncome statementFY2026Open on SEC.gov, accession 0001304492-26-000027, leaves this page and opens in a new tabForm10-KFiledJun 25, 2026PeriodFY2026Accession0001304492-26-000027What we read from itBalance sheetFY2026Open on SEC.gov, accession 0001304492-26-000027, leaves this page and opens in a new tab
	n/a	FY2026	Oct 15, 2026
n/a The filed cash flow statement reports no dividend paid at all. That is not the same as a filed zero, and we will not read it as one.
FormulaCommon dividends paid in the latest filed year / market capitalisation x 100. n/a where the filing cannot support it: a special or first-year payment, a total that mixes preferred dividends, or a cash-flow statement over 15 months old. As ofThe close on Oct 15, 2026, over the filed figures of FY2026: a price is in this figure, and it moved after the filing. Form10-KFiledJun 25, 2026PeriodFY2026Accession0001304492-26-000027What we read from itCash flow statementFY2026Open on SEC.gov, accession 0001304492-26-000027, leaves this page and opens in a new tab
	n/a	FY2026	Jun 25, 2026
n/a The filed borrowings do not add up to a total we can stand behind: the filer's own liability subtotals leave room for debt we did not read.
FormulaTotal debt / shareholders equity As ofThe filing date of the statements below, for FY2026. Form10-KFiledJun 25, 2026PeriodFY2026Accession0001304492-26-000027What we read from itBalance sheetFY2026Open on SEC.gov, accession 0001304492-26-000027, leaves this page and opens in a new tab
	3.33	FY2026	Jun 25, 2026
FormulaCurrent assets / current liabilities As ofThe filing date of the statements below, for FY2026. Form10-KFiledJun 25, 2026PeriodFY2026Accession0001304492-26-000027What we read from itBalance sheetFY2026Open on SEC.gov, accession 0001304492-26-000027, leaves this page and opens in a new tab
	n/a	FY2026	Oct 15, 2026
n/a Our copy of this filing shows an operating income many times the revenue above it, which that revenue cannot produce, so the revenue line we hold is wrong. We show nothing built on it.
FormulaMarket capitalisation / revenue As ofThe close on Oct 15, 2026, over the filed figures of FY2026: a price is in this figure, and it moved after the filing. Form10-KFiledJun 25, 2026PeriodFY2026Accession0001304492-26-000027What we read from itIncome statementFY2026Open on SEC.gov, accession 0001304492-26-000027, leaves this page and opens in a new tab
	n/a	FY2026	Oct 15, 2026
n/a This figure compares a year against the one before it, and we hold one filed year for this company.
FormulaPrice to earnings / the annual earnings growth rate, in percentage points As ofThe close on Oct 15, 2026, over the filed figures of FY2026: a price is in this figure, and it moved after the filing. Form10-KFiledJun 25, 2026PeriodFY2026Accession0001304492-26-000027What we read from itIncome statementFY2026Open on SEC.gov, accession 0001304492-26-000027, leaves this page and opens in a new tab
	n/a	FY2026	Oct 15, 2026
n/a Our copy of this filing shows an operating income many times the revenue above it, which that revenue cannot produce, so the revenue line we hold is wrong. We show nothing built on it.
Formula1.2 x working capital/assets + 1.4 x retained earnings/assets + 3.3 x EBIT/assets + 0.6 x market value of equity/total liabilities + 1.0 x revenue/assets As ofThe close on Oct 15, 2026, over the filed figures of FY2026: a price is in this figure, and it moved after the filing. Form10-KFiledJun 25, 2026PeriodFY2026Accession0001304492-26-000027What we read from itIncome statementFY2026Open on SEC.gov, accession 0001304492-26-000027, leaves this page and opens in a new tabForm10-KFiledJun 25, 2026PeriodFY2026Accession0001304492-26-000027What we read from itBalance sheetFY2026Open on SEC.gov, accession 0001304492-26-000027, leaves this page and opens in a new tab
	n/a	FY2026	Jun 25, 2026
n/a Our copy of this filing shows an operating income many times the revenue above it, which that revenue cannot produce, so the revenue line we hold is wrong. We show nothing built on it.
FormulaAn eight-variable index of year-on-year changes in receivables, gross margin, asset quality, revenue, depreciation, overheads, leverage and accruals As ofThe filing date of the statements below, for FY2026. Form10-KFiledJun 25, 2026PeriodFY2026Accession0001304492-26-000027What we read from itIncome statementFY2026Open on SEC.gov, accession 0001304492-26-000027, leaves this page and opens in a new tabForm10-KFiledJun 25, 2026PeriodFY2026Accession0001304492-26-000027What we read from itBalance sheetFY2026Open on SEC.gov, accession 0001304492-26-000027, leaves this page and opens in a new tabForm10-KFiledJun 25, 2026PeriodFY2026Accession0001304492-26-000027What we read from itCash flow statementFY2026Open on SEC.gov, accession 0001304492-26-000027, leaves this page and opens in a new tab
	n/a	FY2026	Jun 25, 2026
n/a Our copy of this filing shows an operating income many times the revenue above it, which that revenue cannot produce, so the revenue line we hold is wrong. We show nothing built on it.
FormulaOne point each for: positive return on assets, positive operating cash flow, rising return on assets, operating cash flow above net income, falling leverage, rising current ratio, no new shares issued, rising gross margin, rising asset turnover. As ofThe filing date of the statements below, for FY2026. Form10-KFiledJun 25, 2026PeriodFY2026Accession0001304492-26-000027What we read from itIncome statementFY2026Open on SEC.gov, accession 0001304492-26-000027, leaves this page and opens in a new tabForm10-KFiledJun 25, 2026PeriodFY2026Accession0001304492-26-000027What we read from itBalance sheetFY2026Open on SEC.gov, accession 0001304492-26-000027, leaves this page and opens in a new tabForm10-KFiledJun 25, 2026PeriodFY2026Accession0001304492-26-000027What we read from itCash flow statementFY2026Open on SEC.gov, accession 0001304492-26-000027, leaves this page and opens in a new tab

The figures are computed from the accounts for fiscal 2026, the newest full year on file. 13 filed fiscal years on record, FY2013 to FY2026, from SEC EDGAR. Prices as of Oct 15, 2026. Ratios recomputed Oct 15, 2026. Two facts, because a recompute is not a fresh quote.

The year and the filing date name the statement each figure’s accounts are read from, and they stand even where the figure itself could not be computed: the line beneath a blank says what that statement did not carry. A figure’s name opens its formula and the filings behind it; a statement that names no SEC filing has no filing date, and reads n/a.

Ten years of filed figures, year by year

Ten years of filed figures

10 filed fiscal years, FY2017 to FY2026, read from the annual reports Anterix Inc filed with the SEC. Each year names its filing. Amounts in USD, as filed.

Anterix Inc: revenue, earnings, free cash flow and returns, by fiscal year, with the filing each year was read from
Year	Revenue	Operating income	Net income	EPS, diluted	Free cash flow	Operating margin	Return on equity	Filing
FY2026	6.5M	93.9M	90.6M	4.83	5.5M	n/a	34.5%	10-K, Jun 25, 20260001304492-26-000027
FY2025	6.0M	-11.7M	-11.4M	-0.61	-29.4M	-194.2%	-7.3%	10-K, Jun 24, 20250001304492-25-000056
FY2024	4.2M	-10.1M	-9.1M	-0.49	41.7M	-241.5%	-5.7%	10-K, Jun 26, 20240001304492-24-000077
FY2023	1.9M	-16.5M	-16.3M	-0.87	-29.4M	-857.8%	-9.1%	10-K, Jun 14, 20230001304492-23-000030
FY2022	1.1M	-36.8M	-37.5M	-2.07	16.9M	-3399.3%	-20.1%	10-K, May 26, 20220001304492-22-000020
FY2021	921.0K	-54.8M	-54.4M	-3.13	-10.2M	-5951.0%	-25.6%	10-K, Jun 15, 20210001304492-21-000018
FY2020	1.6M	-37.5M	-37.6M	-2.29	-28.3M	-2399.8%	-15.4%	10-K, May 28, 20200001304492-20-000027
FY2019	6.5M	-42.7M	-42.0M	-2.88	-23.8M	-657.6%	-23.2%	10-K, May 20, 20190001304492-19-000019
FY2018	6.4M	-31.7M	-24.6M	-1.70	-22.9M	-499.2%	-11.7%	10-K, Jun 5, 20180001304492-18-000032
FY2017	4.8M	-32.8M	-39.2M	-2.72	-28.1M	-684.8%	-17.2%	10-K, Jun 6, 20170001304492-17-000020

Revenue, compound annual growth FY2017 to FY2026: 3.5%
Earnings: Earnings was not positive in both 2017 and 2026, so a compound rate across the window is not defined. Both figures are in the table.
Earnings per share: Earnings per share was not positive in both 2017 and 2026, so a compound rate across the window is not defined. Both figures are in the table.
Free cash flow: Free cash flow was not positive in both 2017 and 2026, so a compound rate across the window is not defined. Both figures are in the table.

Every figure in this section is a line of a filed annual statement or a ratio of two of them. Nothing here is estimated or smoothed. Earnings per share filed before a share split are put on today's share count, and say so. Nothing here is a verdict on the company.

8 of 10

Risks and guardrails

The accounting screens, the published tests, and the lines you can set to be told.

ComputedCompany statement

Anterix Inc: accounting screens and published tests, each with its source
Figure	Value, source and document
Beneish M-score Why n/a Our copy of this filing shows an operating income many times the revenue above it, which that revenue cannot produce, so the revenue line we hold is wrong. We show nothing built on it.	n/a ComputedFY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027
Piotroski F-score Why n/a Our copy of this filing shows an operating income many times the revenue above it, which that revenue cannot produce, so the revenue line we hold is wrong. We show nothing built on it.	n/a ComputedFY2026 10-K, filed Jun 25, 2026, 0001304492-26-000027
Named tests met	0 of 30 Computed
Beta	0.53 ComputedClose of Oct 15, 2026

The named tests

Of 30 tests value investors published: 0 met, 18 not met, 12 we could not complete. Counts, never a score: a single figure would have to decide that meeting one investor’s criteria and meeting another’s are worth the same.

Which tests, by name(all 30)

Meets: None of the named tests.
Does not: Defensive investor (Benjamin Graham); Deep value; Large cap, low P/E; High F-score, low P/B (Joseph Piotroski); High yield, low payout; Dividends and buybacks; Near the 52-week low; Two thirds of NCAV (Benjamin Graham); P/E times P/B (Benjamin Graham); High returns, low debt; Owner earnings yield; High return on tangibles; Book or below, low debt (Walter Schloss); Tangible book or below; Cash-flow yield and ROIC; Cheapest quarter on P/E (David Dreman); Cheapest quarter on P/B (David Dreman); Low P/E, growth, yield (John Neff)
Not measured: Earnings yield and ROIC (Joel Greenblatt); Three forensic scores; Low PEG, low debt (Peter Lynch); High returns and growth; Gross margin, turnover (Robert Novy-Marx); EV/EBITDA and coverage; Low beta, profitable; ROIC at or above WACC; Z-score and coverage (Edward Altman); Low P/S, rising earnings (James O'Shaughnessy); Cash-covered dividend; Clean books, high ROIC. A test with a figure we could not read is incomplete, never met and never failed.

Figures we could not read(19)

Debt to Equity: The filed borrowings do not add up to a total we can stand behind: the filer's own liability subtotals leave room for debt we did not read.
Piotroski F-Score: Our copy of this filing shows an operating income many times the revenue above it, which that revenue cannot produce, so the revenue line we hold is wrong. We show nothing built on it.
EV/EBIT: We do not hold this figure for this company, so there is nothing to show.
Return on Invested Capital: The filed borrowings do not add up to a total we can stand behind: the filer's own liability subtotals leave room for debt we did not read.
Altman Z-Score: Our copy of this filing shows an operating income many times the revenue above it, which that revenue cannot produce, so the revenue line we hold is wrong. We show nothing built on it.
Beneish M-Score: Our copy of this filing shows an operating income many times the revenue above it, which that revenue cannot produce, so the revenue line we hold is wrong. We show nothing built on it.
PEG Ratio: We do not hold this figure for this company, so there is nothing to show.
Eps Growth 5Y: We do not hold this figure for this company, so there is nothing to show.
Rev Growth 5Y: Our copy of this filing shows an operating income many times the revenue above it, which that revenue cannot produce, so the revenue line we hold is wrong. We show nothing built on it.
Gross Margin: Our archived statements for this filer carry no gross profit line, so there is nothing to compute a gross margin from and trace back to source. That may be because the filer presents no cost of revenue, or because we have not captured the concept. We do not guess which.
Asset Turnover: Our copy of this filing shows an operating income many times the revenue above it, which that revenue cannot produce, so the revenue line we hold is wrong. We show nothing built on it.
EV/EBITDA: We do not hold this figure for this company, so there is nothing to show.
Interest Coverage: No interest expense is filed for this year, so coverage is not computed.
Dividend Yield: We do not hold this figure for this company, so there is nothing to show.
Payout Ratio: We do not hold this figure for this company, so there is nothing to show.
ROIC-WACC Spread: We do not hold this figure for this company, so there is nothing to show.
P/S Ratio: Our copy of this filing shows an operating income many times the revenue above it, which that revenue cannot produce, so the revenue line we hold is wrong. We show nothing built on it.
Dividend Coverage Ratio: We do not hold this figure for this company, so there is nothing to show.
Dividend Streak: We do not hold this figure for this company, so there is nothing to show.

9 of 10

Declared positions

Whether anybody here owns this company.

Positions declared by the founder: no holding in any company shown here, as of October 3, 2026.

10 of 10

Next step

What to do with what you have read.

Value it in the DCF workbench

A thesis is your reason for owning it, in your words, with the figures that must stay true. Checking those figures every night against the newest filed accounts, and telling you once when one breaks, is what the subscription adds.

What this cannot tell you

19 figures could not be read on this company, among them Debt to Equity, Piotroski F-Score, EV/EBIT. Each blank in the table above names the rest, with its reason. 12 named tests come back incomplete because of them, which is neither met nor missed.

And the one that is true of all of it: This is what the numbers say today. It cannot tell you the day one of them stops being true. Nothing here can, because the reasons are not written down.

Running this once is arithmetic on public documents and you are welcome to it. Writing down why you own each company, in your own words and with the numbers that have to stay true for it to hold, and then having those numbers re-checked every night against the newest filed accounts, and against the latest close where a rule watches a price, is Professional, the plan a new account starts on for 30 days, one trial per person. It writes to you the day one breaks, and stays quiet when nothing does. The check runs every night at 23:30 UTC. A filing is picked up the night after it is published.

Monitor my portfolio How this is computed

No card. 30 free days, and nothing is charged unless you choose a plan.

Analyze your own portfolio

ValueScreener · valuescreener.ai · Computed from accounts filed with the SEC by this company, read from EDGAR, and from dated closing prices. On this page a filed figure opens into its formula, its inputs and the statement, fiscal year and filing date it was read from, and a price into the day of its close. A figure that cannot show that trail says so.

A computation on accounts filed with the SEC, not a recommendation and not advice. Past filings do not indicate future results. Risk disclaimer.

Four questions, at a glance

Quality

Financial strength

Valuation

Cash generation

Revenue and net income, as filed

The reading, in brief

Financial health

Valuation

Companies like Anterix Inc

The filed figures

Ten years of filed figures

The named tests

What this cannot tell you

Margin Notes